The experience of using botulinum toxin in neurological practice in the Republic of Tatarstan

Aim. To assess the dynamics of botulinum therapy in the treatment of patients with severe disorders of movement in Tatarstan according to the data of the Clinical and Diagnostic Center for Extrapyramidal Pathology and Botulinum Therapy of the Republic of Tatarstan. Methods. Epidemiological, clinical and statistical analysis of the results of using botulinum therapy in the Republic of Tatarstan. Results. During the period 2004-2010 569 people were referred to the Clinical and Diagnostic Center for Extrapyramidal Pathology and Botulinum Therapy. Meanwhile, given the prevalence of major conditions, in which botulinum therapy is indicated, the number of people needing these injections in the Republic of Tatarstan is at least 1514 pe-ople. With the inclusion of botulinum toxin in 2008 to the list of additional drug provision botulinum therapy become more affordable, this being reflected in the statistics of growth of this type of medical care. Over 80% of those in need of care are young patients of working age, able to return to work through regular botulinum therapy. Botulinum therapy in a number of neurological diseases is virtually the only effective means of symptomatic treatment, which reduces the level of disability. Its advantages are not only its high effectiveness, but also the possibility of conducting the procedure on an outpatient basis. Conclusion. Based on the assessment of the dynamics of botulinum therapy it is considered necessary to establish regional programs, which would provide botulinum toxin to patients who are not disabled, but acutely in need of injections.

botulinum therapy, dystonia, extrapyramidal pathology, spasmodic torticollis, blepharospasm